Solid Biosciences Inc.

NASDAQ:SLDB

Biotechnology

Healthcare
$6.23 +3.63%

+$0.27 today

Market cap
$695.33M
Beta
2.43
P/E (TTM)
-4.3
EPS (TTM)
-$1.75
52W Low $3.79High $8.87

Volume 1.13M

Average 1.39M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$179.21M

FY 2025 · Annual

Net Income

-$174.32M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.62M8.09M000
Cost of Revenue002.58M2.46M1.64M
Gross Profit13.62M8.09M(2.58M)(2.46M)(1.64M)
Gross Margin100.0%100.0%———
Research & Development58.74M78.42M76.56M96.43M140.33M
Selling, General & Admin27.14M28.95M27.75M33.3M38.88M
Operating Expenses85.87M114.55M101.73M127.27M177.57M
Depreciation & Amortization2.96M2.41M2.58M2.46M1.64M
EBITDA(69.22M)(96.87M)(93.43M)(121.9M)(172.69M)
EBITDA Margin-508.3%-1196.8%———
Operating Income(72.25M)(106.45M)(104.32M)(129.73M)(179.21M)
Operating Margin-530.5%-1315.2%———
Interest Income64K2.62M7.14M9.47M9.9M
Interest Expense000340K0
Other Income / Expenses66K20.47M8.3M5.03M4.88M
Income Before Tax(72.19M)(85.98M)(96.02M)(124.7M)(174.33M)
Pre-Tax Margin-530.0%-1062.3%———
Income Tax Expense00000
Net Income(72.19M)(85.98M)(96.02M)(124.7M)(174.33M)
Net Margin-530.0%-1062.3%———
EPS (Basic)(10.14)(10.10)(4.83)(3.06)(1.99)
EPS (Diluted)(10.14)(10.10)(4.83)(3.06)(1.99)
Weighted Avg Shares7.12M8.51M19.88M40.82M87.5M
Weighted Avg Shares (Diluted)7.12M8.51M19.88M40.82M87.5M

SLDB Earnings Waterfall · TTM

NASDAQ:SLDB · Revenue to Net Income

Key Ratios

EPS$-1.95
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$191.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.95, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 6, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 26, 2026
4Statement of changes in beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 6, 2026

How much revenue does SLDB generate?

Solid Biosciences Inc. (SLDB) reported $0.00 of revenue in fiscal 2025.

Is SLDB profitable?

Solid Biosciences Inc. (SLDB) reported -$174.32M of net income.